| 1 |
35102444 | The clinical utility of TRACP-5b to monitor anti-resorptive treatments of osteoporosis. | 2022 Jun |
1 |
| 2 |
34289682 | Qualitative and quantitative analysis of the CTX in relation to the period of intake of bisphosphonates: A systematic review. | 2021 May-Jun |
3 |
| 3 |
32426015 | Can bone turnover markers help to define the suitability and duration of bisphosphonate drug holidays? | 2020 |
2 |
| 4 |
31256304 | Bone union after spinal fusion surgery using local bone in long-term bisphosphonate users: a prospective comparative study. | 2019 Jun 29 |
1 |
| 5 |
31256803 | Serum C-terminal cross-linking telopeptide level as a predictive biomarker of osteonecrosis after dentoalveolar surgery in patients receiving bisphosphonate therapy: Systematic review and meta-analysis. | 2019 Aug |
3 |
| 6 |
27876532 | Efficacy of the C-terminal telopeptide test in predicting the development of bisphosphonate-related osteonecrosis of the jaw: a systematic review. | 2017 Feb |
1 |
| 7 |
28540505 | Retrospective evaluation of serum CTX levels after denosumab discontinuation in patients with or without prior exposure to bisphosphonates. | 2017 Sep |
6 |
| 8 |
25863230 | High C-Terminal Cross-Linking Telopeptide Levels Are Associated With a Minimal Risk of Osteonecrosis of the Jaws in Patients Taking Oral Bisphosphonates and Having Exodontia. | 2015 Sep |
1 |
| 9 |
25944731 | Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials. | 2015 Sep |
3 |
| 10 |
23920073 | C-terminal cross-linking telopeptide as a serologic marker for bisphosphonate-related osteonecrosis of the jaw: review of 2 cases. | 2013 |
2 |
| 11 |
23954759 | Prospective biomarker evaluation in patients with osteonecrosis of the jaw who received bisphosphonates. | 2013 Nov |
1 |
| 12 |
22143730 | Study of serum CTX in 50 oral surgical patients treated with oral bisphosphonates. | 2012 May 1 |
1 |
| 13 |
22223192 | A role for C-terminal cross-linking telopeptide (CTX) level to predict the development of bisphosphonate-related osteonecrosis of the jaws (BRONJ) following oral surgery? | 2012 Jun |
1 |
| 14 |
22783453 | Surgical protocol in patients at risk for bisphosphonate osteonecrosis of the jaws: clinical use of serum telopetide CTX in preventive monitoring of surgical risk. | 2012 Jan |
2 |
| 15 |
20147814 | CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part II: a prospective clinical study. | 2010 Feb |
2 |
| 16 |
20674404 | Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers. | 2010 Oct |
1 |
| 17 |
19925985 | Correlation between serum C-terminal cross-linking telopeptide of type I collagen and staging of oral bisphosphonate-related osteonecrosis of the jaws. | 2009 Dec |
1 |
| 18 |
18022461 | Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. | 2007 Dec |
3 |
| 19 |
16319976 | Can bone markers guide more effective treatment of bone metastases from breast cancer? | 2006 May |
1 |
| 20 |
10652955 | Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. | 2000 Feb |
1 |
| 21 |
10773591 | Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy. | 2000 May |
2 |
| 22 |
10958874 | Comparison of urinary markers for bone resorption in multiple myeloma. | 2000 Oct |
1 |
| 23 |
9648471 | [Biochemical markers of bone metabolism]. | 1998 Jun |
1 |
| 24 |
9284739 | Short-term variations in bone remodeling biochemical markers: cyclical etidronate and alendronate effects compared. | 1997 Sep |
1 |